Matthew Henn, based in Boston, MA, US, is currently a President and Chief Scientific Officer at Seres Therapeutics. Matthew Henn brings experience from previous roles at Seres Therapeutics, Seres Therapeutics (formally Seres Health) and Seres Health. Matthew Henn holds a 1997 - 2002 Ph.D. in Ph.D., Microbiology; Ecosystem Sciences @ University of California, Berkeley. With a robust skill set that includes Genomics, Microbiology, Infectious Diseases, Sequencing, Data Analysis and more. Matthew Henn has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Matthew Henn?
Find contact details for 700 million professionals.